The EDQM continues to inspect manufacuturers of APIs - especially in Asia. As a consequence of these inspections a number of CEPs were supspended or withdrawn (GMP News 20.1.2010 and GMP News 29.04.2009). In addition to previous announcements the EDQM published the suspension of 3 and the withdrawal of 4 CEPs on their website.  All of the CEP owners are Indian and Chinese companies.

The EDQM announces the suspension of the following CEPs as a result of an inspection of the manufacturing sites:

Date	Substance name	CEP Number
14/12/2009	Carbamazepine	CEP 2002-141
31/03/2010	Chlorpropamide	CEP 2000-020
31/03/2010	Tolbutamide	CEP 2000-021

The EDQM announces the withdrawal of the following CEP as a result of an inspection of the manufacturing sites:

Date	Substance name	CEP Number
26/02/2010	Propyphenazone	CEP 2001-041
26/02/2010	Phenazone	CEP 2001-042
26/02/2010	Metamizole sodium	CEP 2001-220
04/01/2010	Zidovudine	CEP 2003-276

The EDQM offers a database in which the information on the Certificates of Suitability (CEPs) are available for public. The database offers a comprehensive search tool. It is possible to search for:

• Name of the certified substance or
• Holder of the certificate or
• Certificate number or
• Monograph number or
• Status of the certificate

The database can be found here.

Source: www.edqm.eu.

Related GMP News
12/06/2013	GMP-Audits of manufacturers of active substances: Minimum Requirements on Audit Reports and Qualification of Auditors
29/05/2013	Canada: GMP Requirements now Applicable to all APIs
08/05/2013	Written Confirmation: Australia gets on the List of "Third Countries"
24/04/2013	Written Confirmations: Questions & Answers Document Version 4.1 published!
17/04/2013	Comparison of EU GMP and Indian GMP Requirements for APIs